Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study
Globe Newswire21-02-2023, 10:53
Contact Center Publication Releases Predictions for Call 1-02-2023, 00:22